• to decrease the potential risk of significant cardiovascular (coronary heart and blood vessel) complications in adults with kind 2 diabetes and heart problemsIn Oct 2024, Novo Nordisk printed a review on scientific journal Nature a few novel glucose-sensitive insulin NNC2215 which will cut down the chance of hypoglycemia in animal styles.[67]We